APTIMA CT (ACT) and APTIMA GC (AGC) are two discrete NAATs for C. trachomatis and N. gonorrhoeae detection that are suitable for confirming AC2-positive results because they target different nucleic acid sequences.

Vaginal swabs identified as many infected patients as endocervical swabs and more than FCUs, and may well be the specimen of choice for screening. Vaginal swab specimens allowed sensitive and specific detection of CT and GC in the APTIMA assays.

A clinical evaluation was conducted in six North American centers to determine the ability of APTIMA CT (ACT) and APTIMA GC (AGC) nucleic acid amplification assays to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections in 1,322 men by testing their urethral swabs and first-catch urine (FCU). The results obtained with ACT and AGC ...

Nucleic acid amplification tests (NAATs) are recommended for the diagnosis of chlamydia and gonorrhoea due to their high sensitivity and specificity, 1–3 but a variety of urogenital specimens (ie, urine, cervical and vaginal) are used for testing at clinic level.

For this reason, a careful workup of the patient is usually indicated, including colposcopy, directed cervical biopsies, endocervical sampling and repeat cytology. Endometrial biopsy should be performed in women over age 35, women with abnormal bleeding, and women whose atypical glandular cells are endometrial in appearance.

APTIMA GC (AGC) are target amplification nucleic acid probe tests that utilize target capture, transcription mediated amplification and hybridization protection to detect rRNA. ACT and AGC utilize different target sequences than AC2 and thus may be used for confirmation of positive NAAT results, as well as stand-alone tests.

The Gen-Probe APTIMA Combo 2 (AC2) is a Food and Drug Administration-cleared nucleic acid amplification test (NAAT) for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae from urine and urogenital swab specimens. The Centers for Disease Control and Prevention have recommended confirmat …

Vaginal specimen collected with pink swab from Aptima MultiTest Swab Collection kit (ARUP supply #55224 PK/50 or #55229 PK/10) available online through eSupply using ARUP Connect or contact Client Services at (800) 522-2787.

Culture for GC using transport swabs performs poorly in asymptomatic men, symptomatic and asymptomatic women and at extra-genital sites. With the improved performance of nucleic acid amplification tests and the increase in GC antimicrobial resistance, research is needed into how best to optimise GC culture in settings where direct plating is ...

A clinical evaluation was conducted in six North American centers to determine the ability of APTIMA CT (ACT) and APTIMA GC (AGC) nucleic acid amplification assays to detect Chlamydia trachomatis...